Actionable Stock Market Trading Newswire. Built for Traders, by Traders.
All news is property of their respective owners.

Home Newsfeeds Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130

Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:META) with a Equal-Weight and raises the price target from $100 to $130.

byBenzinga Newsdesk

January 18, 2023

1 minute read

Morgan Stanley analyst Brian Nowak maintains Meta Platforms (NASDAQ:META) with a Equal-Weight and raises the price target from $100 to $130.

SVB Leerink Maintains Outperform on Merck & Co, Raises Price Target to $122

By Benzinga Newsdesk

February 3, 7:30 AM

SVB Leerink analyst Daina Graybosch maintains Merck & Co (NYSE:MRK) with a Outperform and raises the price target from $120 to $122.

MRK

News

Here’s Why Snap Is Moving

By Henry Khederian

July 31, 12:00 PM

Snap Inc (NYSE: SNAP) shares are trading higher by 4.77% to $11.20 Monday morning as the stock rebounds after falling on its recent earnings report.

SNAP

News

CVS, Rite Aid Say They Are Reviewing Whether To Sell Abortion Pill

By Michael Horton

January 4, 6:26 PM

-Dow Jones

CVS

$100 Invested In Advanced Micro Devices 5 Years Ago Would Be Worth This Much Today

By Benzinga Insights

November 4, 10:33 AM

Advanced Micro Devices (NASDAQ:AMD) has outperformed the market over the past 5 years by 31.15% on an annualized basis producing an average annual return of 38.96%. Currently, Advanced Micro Devices has a market capitalization of $100.78 billion.

AMD

Morgan Stanley Maintains Equal-Weight on Meta Platforms, Raises Price Target to $130

Related Posts

SVB Leerink Maintains Outperform on Merck & Co, Raises Price Target to $122

Here’s Why Snap Is Moving

CVS, Rite Aid Say They Are Reviewing Whether To Sell Abortion Pill

$100 Invested In Advanced Micro Devices 5 Years Ago Would Be Worth This Much Today